Cardiac Valve Market Forecast 2026–2035: How to Leverage Market Growth
Uncover key drivers, emerging technologies, and competitive movements shaping the spinel cathode materials market from 2026–2035 with trusted insights from The Business Research Company
Starting from its 2026 valuation, what market size is the Cardiac Valve Market expected to reach by 2030?_x000D_
The cardiac valve market size has shown rapid development in recent years. It is anticipated to increase from $12.41 billion in 2025 to $14.24 billion in 2026, registering a compound annual growth rate (CAGR) of 14.8%. The historical expansion of this market can be attributed to a higher incidence of valvular heart diseases, the proliferation of cardiac surgery programs, a rise in the application of mechanical heart valves, improvements in surgical valve techniques, and greater access to cardiac care facilities._x000D_
_x000D_
The cardiac valve market size is anticipated to experience rapid expansion over the coming years. It is projected to achieve a value of $24.02 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 14.0%. This growth throughout the forecast period stems from factors such as increasing demand for transcatheter interventions, a rising focus on elderly cardiac care, the expansion of hybrid cardiac procedures, growing investments in next-generation valve technologies, and increasing adoption of patient-specific valve solutions. Furthermore, significant trends in the forecast period include the increasing adoption of transcatheter valve procedures, a rising demand for bioprosthetic heart valves, a growing preference for minimally invasive valve replacement, the expansion of advanced valve repair techniques, and an enhanced focus on valve durability and performance._x000D_
_x000D_
#Access Your Free Sample Report for In-Depth Market Insights:#_x000D_
https://www.thebusinessresearchcompany.com/sample.aspx?id=7753&type=smp_x000D_
_x000D_
What Drivers Are Driving Adoption Within The Cardiac Valve Market?_x000D_
The increasing occurrence of cardiovascular diseases is projected to stimulate the expansion of the cardiac valve market. The incidence of cardiovascular disease has steadily climbed, primarily due to factors such as smoking, obesity, insufficient physical activity, and other elements that strain the cardiovascular system. A significant cause of coronary artery disease is the buildup of fatty plaques within the arteries. These progressive increases in heart-related conditions have heightened the demand for cardiac valves to address heart valve issues. For example, in October 2024, as per the Centers for Disease Control, a US-based government agency, around 919,032 people died from cardiovascular disease in 2023, representing 1 in every 3 deaths. Consequently, the growing incidence of cardiovascular diseases will drive the growth of the cardiac valve market._x000D_
_x000D_
How Is The Cardiac Valve Market Organized Into Various Segments?_x000D_
The cardiac valve market covered in this report is segmented – _x000D_
_x000D_
1) By Type: Tissue Heart Valves, Transcatheter Heart Valves, Mechanical Heart Valves_x000D_
2) By Position: Aortic Valve, Mitral Valve, Other Positions_x000D_
3) By Treatment: Cardiac Valve Repair, Cardiac Valve Replacement_x000D_
4) By End-Users: Hospital And Clinics, Specialty Centers, Cardiac Research Institute, Other End Users_x000D_
_x000D_
Subsegments:_x000D_
1) By Tissue Heart Valves: Bioprosthetic Valves (e.g., porcine, bovine), Homograft Valves _x000D_
2) By Transcatheter Heart Valves: Transcatheter Aortic Valve Replacement (TAVR / TAVI) Valves, Transcatheter Mitral Valve Replacement (TMVR) Valves_x000D_
3) By Mechanical Heart Valves: Tilting Disc Valves, Bileaflet Valves, Caged Ball Valves_x000D_
_x000D_
Which Trends Are Guiding The Evolution Of The Cardiac Valve Market?_x000D_
Leading companies in the cardiac valve market are prioritizing the development of technological advancements, such as transfemoral transcatheter mitral valve replacement (TMVR) systems, to address the increasing need for minimally invasive therapies among an aging population experiencing a rise in mitral regurgitation rates. A transfemoral TMVR system operates by utilizing a collapsible frame and biologic valve leaflets, which are introduced through a catheter via the femoral vein, thereby avoiding open-heart surgery. This approach leads to shorter recovery periods, reduced procedural risks, and greater suitability for patients who are otherwise ineligible for surgical intervention. For example, in April 2025, Edwards Lifesciences, a U.S.-based medical device firm, obtained CE Mark approval for its SAPIEN M3 System, marking it as the initial transcatheter mitral valve replacement therapy administered through a transfemoral method. The SAPIEN M3 system integrates a docking mechanism that first secures the natural mitral leaflets and chordae by drawing them inward to establish a stable landing zone, followed by the deployment of a bioprosthetic valve; both components are delivered via a steerable 29 F guide sheath. This particular design facilitates accurate placement, repositioning, and retrieval before final deployment, enhancing procedural safety and broadening treatment options for patients for whom surgery or edge-to-edge repair is not suitable._x000D_
_x000D_
Who Are The Prominent Global Companies Shaping The Cardiac Valve Market Landscape?_x000D_
Major companies operating in the cardiac valve market are Abbott Laboratories, Edwards Lifesciences Corporation, Medtronic plc, Artivion Inc., Meril Life Sciences Pvt Ltd, Lepu Medical Technology Co Ltd, TTK Healthcare Limited, Braile Biomédica, JenaValve Technology Inc., Xeltis AG, Colibri Heart Valve LLC, On-X Life Technologies Inc., Thubrikar Aortic Valve Inc., LifeNet Health Inc., Auto Tissue Berlin GmbH, CryoLife Inc., LivaNova PLC, Foldax Inc., Micro Interventional Devices Inc., InnovHeart Srl _x000D_
_x000D_
#Access The Complete Report For Deeper Market Insights:#_x000D_
https://www.thebusinessresearchcompany.com/report/cardiac-valve-global-market-report_x000D_
_x000D_
Which Geographic Areas Are Emerging As Strong Markets For The Cardiac Valve Market?_x000D_
North America was the largest region in the cardiac valve market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cardiac valve market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_
_x000D_
#Request Your Customized Cardiac Valve Market Research Report for Competitive Advantage:#_x000D_
https://www.thebusinessresearchcompany.com/customise?id=7753&type=smp_x000D_
_x000D_
#Browse Through More Reports Similar to the Global Cardiac Valve Market 2026, By The Business Research Company#_x000D_
_x000D_
Prosthetic Heart Valve Devices And Equipment Global Market Report 2026_x000D_
_x000D_
Cardiovascular Surgery Devices And Equipment Global Market Report 2026_x000D_
_x000D_
Cardiovascular Implants Global Market Report 2026_x000D_
_x000D_
#Get in touch with us:#_x000D_
_x000D_
The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_
Americas +1 310-496-7795_x000D_
Asia +44 7882 955267 & +91 8897263534_x000D_
Europe +44 7882 955267_x000D_
Email us at info@tbrc.info_x000D_
_x000D_
#Follow us on:#_x000D_
_x000D_
LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_
